cancer

As Dr. Denny Laporta eases into semi-retirement in Intensive Care, an award has been established in his honour.

Certain brain cells may be inherently vulnerable to mutations that cause fatal brain tumours in children, says a study co-led by an LDI researcher.

Dr. Emily Kay-Rivest has joined the JGH Department of Otolaryngology-Head and Neck Surgery as a specialist in ear and skull base surgery.

Although exercise is recognized as being good for cancer patients, hematologist Dr. Nathalie Johnson is taking a closer look at how it helps those with lymphoma.

Dr. Solon Schur has joined the JGH Division of Neurosurgery as a member of staff and as Assistant Professor of Neurosurgery.

A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.

Dr. Robin Billick, JGH Chief of Dermatology, is being honoured by the Israel Cancer Research Fund for decades of service in diagnosing cancer and saving lives.

A pace-setting JGH clinic is providing care and support to patients with rare blood cancers, while raising awareness and promoting research.

Many Hope & Cope volunteers were troubled by not being allowed to see cancer patients in person during the pandemic, but now those ties are being re-established.

As the new Director of the Lady Davis Institute, Dr. Stephen Robbins hopes to see the LDI gain even more global prominence.